Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience
- PMID: 34747535
- DOI: 10.1002/humu.24294
Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience
Abstract
Constitutional LZTR1 or SMARCB1 pathogenic variants (PVs) have been found in ∼86% of familial and ∼40% of sporadic schwannomatosis cases. Hence, we performed massively parallel sequencing of the entire LZTR1, SMARCB1, and NF2 genomic loci in 35 individuals with schwannomas negative for constitutional first-hit PVs in the LZTR1/SMARCB1/NF2 coding sequences; however, with 22q deletion and/or a different NF2 PV in each tumor, including six cases with only one tumor available. Furthermore, we verified whether any other LZTR1/SMARCB1/NF2 (likely) PVs could be found in 16 cases carrying a SMARCB1 constitutional variant in the 3'-untranslated region (3'-UTR) c.*17C>T, c.*70C>T, or c.*82C>T. As no additional variants were found, functional studies were performed to clarify the effect of these 3'-UTR variants on the transcript. The 3'-UTR variants c.*17C>T and c.*82C>T showed pathogenicity by negatively affecting the SMARCB1 transcript level. Two novel deep intronic SMARCB1 variants, c.500+883T>G and c.500+887G>A, resulting in out-of-frame missplicing of intron 4, were identified in two unrelated individuals. Further resequencing of the entire repeat-masked genomics sequences of chromosome 22q in individuals negative for PVs in the SMARCB1/LZTR1/NF2 coding- and noncoding regions revealed five potential schwannomatosis-predisposing candidate genes, that is, MYO18B, NEFH, SGSM1, SGSM3, and SBF1, pending further verification.
Keywords: LZTR1; MYO18B; NEFH; NF2; SBF1; SGSM1; SGSM3; SMARCB1; deep intronic variant; low level mosaicism; massively parallel sequencing; schwannomatosis.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Agnihotri, S., Jalali, S., Wilson, M. R., Danesh, A., Li, M., Klironomos, G., Krieger, J. R., Mansouri, A., Khan, O., Mamatjan, Y., Landon-Brace, N., Tung, T., Dowar, M., Li, T., Bruce, J. P., Burrell, K. E., Tonge, P. D., Alamsahebpour, A., Krischek, B., … Zadeh, G. (2016). The genomic landscape of schwannoma. Nature Genetics, 48, 1339-1348.
-
- Bartoszewska, S., Kamysz, W., Jakiela, B., Sanak, M., Kroliczewski, J., Bebok, Z., Bartoszewski, R., & Collawn, J. F. (2017). miR-200b downregulates CFTR during hypoxia in human lung epithelial cells. Cellular and Molecular Biology Letters, 22, 23.
-
- Bartoszewski, R., Gebert, M., Janaszak-Jasiecka, A., Cabaj, A., Kroliczewski, J., Bartoszewska, S., Sobolewska, A., Crossman, D. K., Ochocka, R., & Kamysz, W. (2019). Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress. FEBS Journal, 287, 2923-2947.
-
- Bonfert, T., & Friedel, C. C. (2017). Prediction of poly(A) sites by poly(A) read mapping. PLoS One, 12, e0170914.
-
- Castellanos, E., Bielsa, I., Carrato, C., Rosas, I., Solanes, A., Hostalot, C., Amilibia, E., Prades, J., Roca-Ribas, F., Lazaro, C., Blanco, I., & Serra, E. (2015). Segmental neurofibromatosis type 2: Discriminating two hit form four hit in a patient presenting multiple schwannomas confined to one limb. BMC Medical Genomics, 8, 2.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
